Ethical Dilemma with Stakeholders
You're the CEO of a pharmaceutical company. Your best-selling drug ($2B annual revenue, used by 4 million patients for chronic pain) has…
Here's a specific, hour-by-hour action plan for the next 48 hours, considering all the factors you've mentioned: Day 1: Hour 1-2: Gather all relevant information Meet with your internal research team to get a comprehensive understanding of the side effect, its severity, and the data supporting it.Read the full answer
As CEO, I would not wait six months and I would not let the board delay disclosure while patients remain exposed to an unreported serious risk. I would treat this as a patient-safety, regulatory, legal, and trust crisis—not merely a financial-risk issue. My guiding decisions would be: Patient safety comes first.Read the full answer